Cocoon Biotech
Cambridge
About Cocoon Biotech
Cocoon Biotech’s platform technology is a biocompatible silk protein that can be injected into joints to provide effective long lasting pain relief and potentially delay the progression of disease. This platform will leverage several unique properties of the silk protein fibroin, including strength, lubrication, and biocompatibility. Their mission is to use this technology to significantly improve the treatment of osteoarthritis and other degenerative joint disorders. The osteoarthritis treatment gap alone is currently quite large and new approaches that address both symptoms and disease progression are an urgent need.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.7M
- Funding stage: Seed
- Last round: Seed (Dec 2021)
- Website: cocoonbiotech.com
- Phone: (617)356-7346
Industries & Categories
Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/cocoon-biotech-78190 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.